BHP Acknowledges Emissions Reduction Setbacks as WA Premier Urges Mining Sector to Prioritise Decarbonisation Corporate Enthusiasm for Prediction Markets Persists Amid Regulatory Uncertainty Vestas Wind Systems Stock Slips After Company Warns Margins May Hit Low End of Forecast Indias Competition Regulator Approves Indovida IndiaEPL Merger Trump Seeks Totally Independent New Fed Chair Escalates Pressure on Powells Legacy Goldman Sachs Russias Crude Exports Remain Stable Despite Latest US Sanctions CDNA Q1 2026 Earnings Major EPS Beat Signals StrongerThanExpected Profitability Surrozen Inc SRZN Q1 2026 Earnings Significant EPS Miss Reflects Ongoing ClinicalStage Spending No Revenue Reported FirstEnergy Corp FE Q1 2026 Earnings Narrow EPS Miss Clouds Solid Operational Performance BCC Q1 2026 Earnings EPS Surges Past Estimates with 1826 Surprise PJT Partners Q1 2026 Earnings EPS Misses Estimates Stock Declines VVOS Q4 2025 Earnings EPS Misses Estimates as Loss Widens Stock Gains 431 Ennis Inc EBF Edges Higher Amid Modest Gains Holds Above Key Support ZOOZ Strategy Ltd ZOOZ Surges 858 as It Nears Key Resistance Level Franklin Financial Services FRAF Slides 177 as Stock Tests Key Support Level Runway Growth Finance RWAY Slips Slightly as Shares Test Key Support Levels First Hawaiian Inc FHB Shows Modest Gains Amid Steady Trading Patterns EUChina Competitive Gap for Automotive Suppliers Widening Warns CLEPA AMTD Q4 2020 Earnings Massive EPS Beat Highlights Strong Operational Performance EZCORP Inc EZPW Faces Pressure Shares Decline Over 4 as Key Support Test Looms LINKBANCORP Inc LNKB Holds Steady at 869 as Support and Resistance Levels Tighten Cheesecake Factory CAKE Edges Higher Testing Key Resistance Zone as Volume Patterns Shift Xos Inc XOS Holds Steady at 210 Key Support and Resistance in Focus New York Times NYT Modestly Higher as Subscriber Growth and Brand Strength Drive Sentiment Pagaya Technologies Warrants PGYWW Struggle Near Par as Price Holds at 005 BayCom Corp BCML Edges Higher Holding Above Key Support After Modest Advance PRAX Shows Strength Praxis Precision Medicines Gains 245 as Biotech Momentum Builds